@Waltika @Awithonelison Citation here https://t.co/m1YHz4cwoE
@DavidNemer @TwitterBrasil https://t.co/mNvfo5chdI Sugiro a leitura da revisão.
Revue Cochrane sur l’utilisation des inhibiteurs de la phosphodiestérase 5 pour le traitement de l’hypertension pulmonaire https://t.co/LTfOymei8a https://t.co/BXiI3Y8Go3
RT @IlindelatorreMD: Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
RT @IlindelatorreMD: Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
RT @IlindelatorreMD: Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
RT @IlindelatorreMD: Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
RT @IlindelatorreMD: Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
Inhibidores de la fosfodiesterasa 5 para la hipertensión pulmonar. https://t.co/nXnbTmV5yi
Phosphodiesterase 5 inhibitors for #pulmonaryhypertension (PH): PDE5 inhibitors appear to have clinical benefit in group 1 PAH. No clear benefit for PDE5 inhibitors in PH secondary to lung disease or chronic thromboembolic disease | https://t.co/bptlGd44an
RT @Cochrane_Child: New #CochraneEvidence: Phosphodiesterase 5 inhibitors for #pulmonaryhypertension | https://t.co/bptlGd44an #childhealth…
New #CochraneEvidence: Phosphodiesterase 5 inhibitors for #pulmonaryhypertension | https://t.co/bptlGd44an #childhealth https://t.co/ambAS4XpzW
Inhibidores de fosfodiesterasa-5 para el tratamiento de Hipertensión Pulmonar (HP):Una RS y metaanálissis Cochrane: ✅36 estudios con HP de todos los grupos (2999 sujetos), 2 estudios en niños. ✅Confirma beneficios en grupo 1, dudoso en grupo 2. 👉 https://
Review: PDE5 inhibitors for #pulmonaryHTN via @CochraneAirways
RT @CochraneAirways: New #CochraneEvidence: Phosphodiesterase 5 inhibitors for pulmonary hypertension https://t.co/4Q5dNvQkKu
RT @hayleynbarnes: Our team has finally published this comprehensive review! https://t.co/VqVpRtNicX
RT @CochraneAirways: Here are the conclusions for the Phosphodiesterase 5 inhibitors for pulmonary hypertension review. I recommend reading…
Our team has finally published this comprehensive review!
RT @CochraneAirways: Here are the conclusions for the Phosphodiesterase 5 inhibitors for pulmonary hypertension review. I recommend reading…
Here are the conclusions for the Phosphodiesterase 5 inhibitors for pulmonary hypertension review. I recommend reading the results for more details – too many patient groups and nuances for me to tweet them all! [1/6] https://t.co/tvP5vkSSox
New #CochraneEvidence: Phosphodiesterase 5 inhibitors for pulmonary hypertension https://t.co/4Q5dNvQkKu
(Cochrane) Seguridad y eficacia de los iPDE5 en hipertensión pulmonar https://t.co/HqdmilZ1Wb https://t.co/coppKCb7tI
PDE5 inhibitors for pulmonary hypertension https://t.co/f4HxAY9xfG